The report highlights ONO's commitment to sustainable growth for society and the company. It highlights ONO's focus on incorporating material issues into its management strategies, delivering original and innovative drugs as a Global Specialty Pharma, and expanding its business domains beyond pharmaceuticals. The report details ONO's significant financial performance, including record highs in revenue and operating profit, and its commitment to aggressive R&D investment. It also emphasizes ONO's dedication to expanding its global presence, especially in the U.S. and Europe, through the establishment of direct sales operations. The report showcases ONO's dedication to nurturing its human capital through diverse talent training and promoting employee engagement. It also emphasizes ONO's commitment to environmental sustainability, including its target of achieving carbon neutrality by 2035 and reducing its greenhouse gas emissions. The report also outlines ONO's commitment to ethical business practices and compliance with laws and regulations.
Go back to company
Ono Pharmaceutical Co Ltd 2023 Corporate Report
Issuing Company Ono Pharmaceutical Co., Ltd.
Report Type Integrated Report
Report Language EN
Report Filesize 7.57 MB
No. of Pages 57 pages
Reporting periodApril 1, 2022-March 31, 2023
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards GRI; SASB; TCFD
Materiality Assessmenttrue